ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)

News

Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors [Yahoo! Finance]
Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average [Yahoo! Finance]
Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average [Yahoo! Finance]
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors [Yahoo! Finance]
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com